Literature DB >> 11391274

Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance.

J M Mylotte1, S Goodnough, A Tayara.   

Abstract

BACKGROUND: There is limited information about antibiotic-resistant organisms in community long-term care facilities (LTCFs). The objective of this study was to obtain data on resistant organisms in residents from community LTCFs admitted to an inpatient acute geriatrics service (AGS).
METHODS: Two studies were performed. In the first study, bacteriology records of all admissions to the AGS for the period from November 1, 1998, through June 30, 2000, were reviewed for resistant organisms (methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant enterococci [VRE], and resistant gram-negative bacilli). In the second study, residents admitted to the AGS during a 2-month period (N = 92 admissions) had surveillance cultures (nares, gastrostomy site, wounds, and urine) for resistant organisms done within 72 hours of admission.
RESULTS: In the retrospective study, there were 727 admissions, of which 437 (60%) had 928 cultures within 72 hours of admission; 590 (64%) cultures grew 1 or more pathogens. Urine (65%) and blood (26%) cultures accounted for 91% of all cultures done. Rates of resistance by culture site were as follows: urine (resistant organism in 16.6% of 373 cultures), blood (6.7% of 60 cultures), wound (52% of 23 cultures), and sputum (40% of 20 cultures). MRSA and enterococci with high-level gentamicin resistance were the most common resistant organisms identified. No VRE were isolated; only 3% of 421 gram-negative isolates were considered resistant strains compared with 19% (P <.001) of gram-positive isolates. In the prospective study, 17% of 92 residents were found to have a resistant organism in 1 or more surveillance cultures; the most common resistant organisms were MRSA and high-level gentamicin-resistant enterococci. Only 1 resident was found to have VRE in a rectal swab culture; resistant gram-negative bacilli also were uncommon.
CONCLUSIONS: Among residents of community LTCFs admitted to an AGS, resistant organisms were identified infrequently (<20% of admissions). MRSA was the most common resistant organism; VRE and resistant gram-negative bacilli were rare. These findings vary from other studies suggesting that there may be geographic variation in the epidemiology of resistant organisms among residents of community LTCFs.

Entities:  

Mesh:

Year:  2001        PMID: 11391274     DOI: 10.1067/mic.2001.114225

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Profile of methicillin-resistant Staphylococcus aureus among nursing home residents in Hawai'i.

Authors:  Fenfang Li; Pamela Arnsberger; F DeWolfe Miller
Journal:  Hawaii Med J       Date:  2010-05

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility.

Authors:  G Mendelson; V Hait; J Ben-Israel; D Gronich; E Granot; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care VII--Guidelines for antibiotic administration in severely injured patients.

Authors:  Michael A West; Ernest E Moore; Michael B Shapiro; Avery B Nathens; Joseph Cuschieri; Jeffrey L Johnson; Brian G Harbrecht; Joseph P Minei; Paul E Bankey; Ronald V Maier
Journal:  J Trauma       Date:  2008-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.